These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2103595)

  • 1. Clotrimazole and bifonazole in the topical treatment of Candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Uter W
    Mycoses; 1990; 33(11-12):567-73. PubMed ID: 2103595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical fluconazole for experimental candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Rüchel R
    Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natamycin (pimaricin) in the treatment of experimental keratomycosis].
    Behrens-Baumann W; Klinge B
    Fortschr Ophthalmol; 1990; 87(3):237-40. PubMed ID: 2376371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natamycin treatment of experimental Candida albicans induced keratomycosis in rabbits.
    Saleem M; Rahman A; Afza N
    West Indian Med J; 2007 Dec; 56(6):526-9. PubMed ID: 18646497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
    Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
    Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis.
    Matsumoto Y; Murat D; Kojima T; Shimazaki J; Tsubota K
    Br J Ophthalmol; 2011 Oct; 95(10):1406-9. PubMed ID: 21097785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
    Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
    Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: report of three cases and literature review.
    Matsumoto Y; Dogru M; Goto E; Fujishima H; Tsubota K
    Cornea; 2005 Aug; 24(6):748-53. PubMed ID: 16015098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the Effectiveness of Ozone Therapy on the Treatment of Experimentally Induced Keratitis with
    Varol K; Koç AN; Çakır Bayram L; Arda H; Keleş İ; Ünlü M; Güneş V; Ekinci G; Karaca Bekdik İ; Atalay MA
    Semin Ophthalmol; 2022 Feb; 37(2):253-264. PubMed ID: 34693871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
    Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
    Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental studies of local therapy of Candida keratomycosis with amphotericin B].
    Behrens-Baumann W; Uter W; Ansorg R
    Klin Monbl Augenheilkd; 1987 Aug; 191(2):125-8. PubMed ID: 3669506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcome of Candida keratitis.
    Sun RL; Jones DB; Wilhelmus KR
    Am J Ophthalmol; 2007 Jun; 143(6):1043-1045. PubMed ID: 17524775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical voriconazole as a novel treatment for fungal keratitis.
    Sponsel W; Chen N; Dang D; Paris G; Graybill J; Najvar LK; Zhou L; Lam KW; Glickman R; Scribbick F
    Antimicrob Agents Chemother; 2006 Jan; 50(1):262-8. PubMed ID: 16377696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal experiment model of keratomycosis].
    Behrens-Baumann W; Uter W; Vogel M; Ansorg R
    Klin Monbl Augenheilkd; 1987 Jun; 190(6):496-500. PubMed ID: 3626408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal anesthetic abuse and Candida keratitis.
    Chern KC; Meisler DM; Wilhelmus KR; Jones DB; Stern GA; Lowder CY
    Ophthalmology; 1996 Jan; 103(1):37-40. PubMed ID: 8628558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
    Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
    Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative trial of bifonazole 1% cream and clotrimazole 1% cream in the treatment of candidal balanoposthitis.
    Maw RD; Horner T; Evans J
    Mykosen; 1987 May; 30(5):229-32. PubMed ID: 3614264
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of quantitative methods of measuring antifungal drug effects in the rabbit cornea.
    Oji EO
    Br J Ophthalmol; 1981 Feb; 65(2):89-96. PubMed ID: 7006679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.